NCT06144164 A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer Status RECRUITING Phase PHASE3
NCT06142344 Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients Status RECRUITING Phase NA
NCT06139588 Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction Status COMPLETED Phase N/A
NCT06137833 Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy Status RECRUITING Phase NA
NCT06136923 An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer Status COMPLETED Phase NA
NCT06135714 Metastasis-directed Therapy for Oligometastases of Breast Cancer Status RECRUITING Phase PHASE3
NCT06135194 Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib Status RECRUITING Phase N/A
NCT06134570 ALDH1A1 Expression in Invasive Mammary Carcinoma Status ENROLLING_BY_INVITATION Phase N/A
NCT06133959 Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast Cancer Status NOT_YET_RECRUITING Phase NA
NCT06133452 Clinical Outcomes of Patients Undergoing Skin-Reducing Mastectomies Status COMPLETED Phase N/A
NCT06130111 Spatial Location of Breast Cancer Local Recurrence After Mastectomy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06129786 Overcoming Therapy Resistance in ER+ Breast Cancer Patients: a Translational Project (OVERTuRE) Status RECRUITING Phase N/A
NCT06129747 Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast Status RECRUITING Phase PHASE2
NCT06127979 A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery Status RECRUITING Phase NA
NCT06127797 Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue Status RECRUITING Phase N/A
NCT06126406 Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06126003 Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. Status TERMINATED Phase N/A
NCT06125522 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2